Yamanouchi's Vaprisol Goes To Advisory Committee Sept. 9 As First Hyponatremia Drug

The company estimates 1% to 6% of hospitalized patients have the electrolyte disorder, also known as water poisoning. Conivaptan was eligible for priority review, but the firm opted for a 10-month clock to allow time for an advisory committee review.